RecruitingNot ApplicableNCT07075601

Non-interventional Study Exploring the Composition of the Valvular Microbiota of Patients Undergoing Cardiac Surgery


Sponsor

University Hospital, Toulouse

Enrollment

200 participants

Start Date

Nov 19, 2025

Study Type

INTERVENTIONAL

Conditions

Summary

The prevalence of aortic valve disease is increasing, with these valvulopathies present in half of individuals over the age of 65. Oberbach A. et al (1) demonstrated the presence of microbiota in 52% of cases of explanted aortic valves. One current hypothesis is the role of this microbiota in the pathophysiology of these degenerative valve diseases. This microbiota is probably not completely eradicated after resection of the native valve and implantation of a conventional prosthesis; it is even left in place during percutaneous aortic valve implantation, during which the prosthesis is deployed within the native valve. It could therefore also play a role in the occurrence of postoperative complications and the degeneration or thrombosis of a bioprosthesis. Furthermore, recent clinical and epidemiological studies have shown a link between oral infections and cardiovascular diseases. As recommended by the HAS, these patients require multidisciplinary care, involving cardiologists, cardiac surgeons and general practitioners, as well as careful oral and dental care and monitoring provided by specialists in oral pathologies and oral care. The accumulation of bacterial plaque on the surface of the tooth and certain oral bacteria causes the development of periodontal pockets which are characteristic of periodontitis. Bacteria, microbial products and inflammatory mediators produced locally can then enter the bloodstream and affect distant organs such as the cardiovascular system. The recommendations of the European Society of Cardiology are therefore to carry out regular oral and dental consultations to prevent the risk of infection. Therefore, within the Toulouse University Hospital, a care network has been set up for patients with cardiovascular pathologies, in order to improve their access to dental care, screening and management of oral diseases. For the past year, patients hospitalized in the cardiology departments have been seen in consultation in the dental department of the Toulouse University Hospital.


Eligibility

Min Age: 18 Years

Inclusion Criteria4

  • Male or female patient.
  • Present an indication for cardiac surgery that requires explantation of the aortic valve.
  • Be able to receive information about the study process and understand the study participation information form.
  • State their non-opposition to participating in the study.

Exclusion Criteria4

  • Patients infected with HIV
  • Age under 18
  • Under court supervision, guardianship, or curatorship
  • Patients with a history of infective endocarditis.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALTake 1 ml of blood

Take 1 ml of blood

BIOLOGICALDNA sequencing

DNA sequencing

PROCEDUREValve collection (healthcare waste)

Valve collection (healthcare waste)

OTHERCollection of serious post-operative complications

Collection of serious post-operative complications


Locations(1)

Rangueil Hospital

Toulouse, France, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07075601


Related Trials